RECT Stock Analysis: Recticel | BR
Building Products & Equipment | BR, Belgium | Market Cap: 707m EUR | 12M Return: 44.5% | BE0003656676 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 568K
Qual. Beats: 0
Rev. Trend: 81.6%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality
Recticel is a Belgium-based insulation and engineered materials company serving construction, transport, industrial, and other markets. Its products include PIR and mineral wool insulation boards and panels, vacuum insulation, acoustic and vibration-control materials, and modular building components.
The company also provides acoustic engineering, laboratory, and testing services. Insulation products help reduce heat transfer and noise in buildings, while engineered materials serve applications such as vehicles, industrial equipment, and energy infrastructure. Recticel was founded in 1896 and is headquartered in Brussels.
- EU building-efficiency rules support insulation demand and retrofit growth
- Weak European construction activity pressures insulation and panel volumes
- Energy and raw-material costs shape margins amid pricing competition
| Net Income: -5.49m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 2.01 > 1.0 |
| NWC/Revenue: 20.87% < 20% (prev 29.96%; Δ -9.10% < -1%) |
| CFO/TA 0.07 > 3% & CFO 65.0m > Net Income -5.49m |
| Net Debt (51.3m) to EBITDA (50.3m): 1.02 < 3 |
| Current Ratio: 1.42 > 1.5 & < 3 |
| Outstanding Shares: last quarter (56.4m) vs 12m ago -0.23% < -2% |
| Gross Margin: 17.74% > 18% (prev 17.11%; Δ 0.63% > 0.5%) |
| Asset Turnover: 86.08% > 50% (prev 72.60%; Δ 13.48% > 0%) |
| Interest Coverage Ratio: 3.63 > 6 (EBIT TTM 17.5m / Interest Expense TTM 4.82m) |
| A: 0.15 (Total Current Assets 504.1m - Total Current Liabilities 356.0m) / Total Assets 957.1m |
| B: 0.15 (Retained Earnings 146.3m / Total Assets 957.1m) |
| C: 0.02 (EBIT TTM 17.5m / Avg Total Assets 824.8m) |
| D: 0.71 (Book Value of Equity 395.1m / Total Liabilities 558.0m) |
| Altman-Z'' = 2.40 = A |
| DSRI: 0.94 (Receivables 176.5m/133.3m, Revenue 710.0m/502.8m) |
| GMI: 0.96 (GM 17.11% / 17.74%) |
| AQI: 0.84 (AQ_t 0.22 / AQ_t-1 0.26) |
| SGI: 1.41 (Revenue 710.0m / 502.8m) |
| TATA: -0.07 (NI -5.49m - CFO 65.0m) / TA 957.1m) |
| Beneish M = -2.92 (Cap -4..+1) = A |
As of October 30, 2026, the stock is trading at EUR 12.42 with a total of 140,584 shares traded. Over the past week, the price has changed by +13.32%, over one month by -6.76%, over three months by +2.31% and over the past year by +44.50%.
Current recommended Stop Loss: 11.90 (which is 4.2% or 1.4 ATR below the current price).
Recticel has no consensus analysts rating.
P/E Trailing = 33.5676
P/E Forward = 22.6244
P/S = 0.9953
P/B = 1.6304
P/EG = 0.1438
Revenue TTM = 710.0m EUR
EBIT TTM = 17.5m EUR
EBITDA TTM = 50.3m EUR
Long Term Debt = 104.8m EUR (from longTermDebt, last quarter)
Short Term Debt = 18.5m EUR (from shortTermDebt, last quarter)
Debt = 182.6m EUR (from shortLongTermDebtTotal, last quarter) + Leases 32.7m
Net Debt = 51.3m EUR (calculated: Debt 182.6m - CCE 131.3m)
Enterprise Value = 758.0m EUR (706.7m + Debt 182.6m - CCE 131.3m)
Interest Coverage Ratio = 3.63 (Ebit TTM 17.5m / Interest Expense TTM 4.82m)
EV/FCF = 115.3x (Enterprise Value 758.0m / FCF TTM 6.58m)
FCF Yield = 0.87% (FCF TTM 6.58m / Enterprise Value 758.0m)
FCF Margin = 0.93% (FCF TTM 6.58m / Revenue TTM 710.0m)
Net Margin = -0.77% (Net Income TTM -5.49m / Revenue TTM 710.0m)
Gross Margin = 17.74% ((Revenue TTM 710.0m - Cost of Revenue TTM 584.1m) / Revenue TTM)
Gross Margin QoQ = 17.77% (prev 17.70%)
Tobins Q-Ratio = 0.79 (Enterprise Value 758.0m / Total Assets 957.1m)
Interest Expense / Debt = 2.64% (Interest Expense 4.82m / Debt 182.6m)
Taxrate = 17.54% (4.56m / 26.0m)
NOPAT = 14.5m (EBIT 17.5m * (1 - 17.54%))
Current Ratio = 1.42 (Total Current Assets 504.1m / Total Current Liabilities 356.0m)
Debt / Equity = 0.46 (Debt 182.6m / totalStockholderEquity, last quarter 395.1m)
Debt / EBITDA = 1.02 (Net Debt 51.3m / EBITDA 50.3m)
Debt / FCF = 7.80 (Net Debt 51.3m / FCF TTM 6.58m)
Total Stockholder Equity = 417.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.67% (Net Income -5.49m / Total Assets 957.1m)
RoE = -1.31% (Net Income TTM -5.49m / Total Stockholder Equity 417.9m)
RoCE = 3.35% (EBIT 17.5m / Capital Employed (Equity 417.9m + L.T.Debt 104.8m))
RoIC = 2.47% (NOPAT 14.5m / Invested Capital 584.1m)
WACC = 6.03% (E(706.7m)/V(889.3m) * Re(7.03%) + D(182.6m)/V(889.3m) * Rd(2.64%) * (1-Tc(0.18)))
Discount Rate = 7.03% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 4.76 | Cagr: 0.15%
[DCF] Terminal Value 75.44% ; FCFF base≈6.58m ; Y1≈6.60m ; Y5≈6.99m
[DCF] Fair Price = 1.01 (EV 108.8m - Net Debt 51.3m = Equity 57.5m / Shares 56.9m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: 81.56 | Revenue CAGR: 12.65% | SUE: 1.44 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=0.41 | Chg30d=-0.48% | Revisions=-57% | GrowthEPS=+9.6% | GrowthRev=+15.8%
EPS next Year (2027-12-31): EPS=0.55 | Chg30d=-1.91% | Revisions=+0% | GrowthEPS=+33.0% | GrowthRev=+8.3%
[Analyst] Revisions Ratio: -36% (up=2, down=6)